Stay updated on ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial
Sign up to get notified when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.

Latest updates to the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.4.2 was applied, adding USWM CT, LLC and USWM, LLC (dba US WorldMeds) as sponsors/collaborators. Prior collaborators and IPD sharing plan references were removed.SummaryDifference0.8%

- Check48 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1; no substantive content or functionality changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page adds a glossary toggle and new QC-related metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) and removes the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check70 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.